Recombinant interleukin 2 therapy in severe combined immunodeficiency disease.
Severe combined immunodeficiency disease (SCID) is a congenital disorder of severe B- and T-lymphocyte dysfunction in which several pathogenic mechanisms have been identified. The present study describes a female child with SCID who had a primary defect in the ability of T cells to secrete interleuk...
Kaydedildi:
| Yayımlandı: | Proc Natl Acad Sci U S A |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
National Academy of Sciences
1989
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC297558/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2787027/ https://ncbi.nlm.nih.govhttps://doi.org/10.1073/pnas.86.13.5069 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|